Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC24H38N4O6S2 |
InChIKeyMEJLVLMAJJRLCR-GCCNXGTGSA-N |
CAS Registry390745-19-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | 15 Apr 2004 |